Document is current
Any future updates will be listed below
-
Authors
Bruxvoort, Katia J.
Fischer, Heidi
Lewnard, Joseph A.
Hong, Vennis X.
Pomichowski, Magdalena
Grant, Lindsay R.
Jódar, Luis
Gessner, Bradford D.
Tartof, Sara Y.
- License Information
-
More Information
Article History
Received: 2 June 2023
Accepted: 17 September 2023
First Online: 5 October 2023
Declarations
:
: The study was approved by the KPSC Institutional Review Board, which granted a waiver of informed consent and determined that the study posed minimal risk to study participants (IRB approval number 12496).
: Not applicable.
: KJB has received grant funding from Dynavax Technologies, GlaxoSmithKline, and Moderna unrelated to this study. JAL has received grant funding and consulting fees from Pfizer, Merck, Sharp & Dohme, and VaxCyte unrelated to this study. SYT has received grant funding from Genentech and Pfizer unrelated to this study. LRG, LJ, and BDG are employees of Pfizer, Inc. HF, VH, and MP have no conflicts of interest.
